Jasper TherapeuticsJSPR
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 60 institutions reported holding Jasper Therapeutics Inc. (JSPR) in their 13F filings, down 5 from Q2 2025. 15 opened new positions and 20 sold out. The largest holders were Velan Capital Investment Management LP ($6.2M), Soleus Capital Management, L.P. ($3.6M) and Acorn Capital Advisors, LLC ($3.3M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Jasper Therapeutics Inc.
- CUSIP
- 471871202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $12.5M |
| Exits | 20 | $8.3M |
All 13F filers, Q2 2025 → Q3 2025: 9,960,341 shares bought and 2,319,239 shares sold, net +7,641,102 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 60 holders
| Velan Capital Investment Management LP | 5.83% | Add +86.1% | 2,668,395 | $6.2M |
| Soleus Capital Management, L.P. | 0.19% | No change | 1,494,420 | $3.6M |
| Acorn Capital Advisors, LLC | 1.67% | New | 1,382,640 | $3.3M |
| Kingdon Capital Management, L.L.C. | 0.49% | Add +93.5% | 1,324,845 | $3.2M |
| Rock Springs Capital Management LP | 0.15% | Add +101.9% | 1,100,726 | $2.6M |
| Carlyle Group Inc. | 0.06% | No change | 1,066,189 | $2.5M |
| Woodline Partners LP | 0.01% | New | 1,039,751 | $2.5M |
| Vanguard Group Inc. | 0.00% | Add +65.4% | 1,032,842 | $2.5M |
| T. Rowe Price Investment Management, Inc. | 0.00% | Add +46.2% | 1,028,806 | $2.4M |
| Propel Bio Management, LLC | 2.45% | New | 1,028,806 | $2.4M |
| Qiming U.S. Ventures Management, LLC | 3.97% | No change | 928,964 | $2.2M |
| Morgan Stanley | 0.00% | Add +2.6% | 789,960 | $1.9M |
| Sphera Funds Management LTD. | 0.36% | Add +4190.6% | 629,470 | $1.5M |
| Simplify Asset Management Inc. | 0.03% | New | 609,053 | $1.4M |
| Citadel Advisors | 0.00% | Add +43.6% | 589,449 | $1.4M |
| Boothbay Fund Management, LLC | 0.03% | New | 442,642 | $1.1M |
| Lion Point Capital, LP | 5.39% | Add +172.1% | 398,558 | $949K |
| Millennium Management | 0.00% | Add +151.3% | 364,939 | $869K |
| Armistice Capital, LLC | 0.03% | New | 348,000 | $828K |
| Bank of America Corp. | 0.00% | Add +0.4% | 294,553 | $701K |
| Renaissance Technologies | 0.00% | Add +1904.8% | 208,500 | $496K |
| BlackRock, Inc. | 0.00% | Reduce -9.2% | 204,932 | $488K |
| Knott David M Jr | 0.17% | New | 171,389 | $408K |
| Deutsche Bank AG | 0.00% | No change | 160,000 | $381K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.2% | 130,855 | $312K |
| Bank of Montreal | 0.00% | Reduce -29.3% | 111,802 | $266K |
| Readystate Asset Management LP | 0.02% | New | 98,439 | $234K |
| Ieq Capital, LLC | 0.00% | New | 48,118 | $115K |
| State Street Corp. | 0.00% | Reduce -0.1% | 44,699 | $106K |
| Osaic Holdings, Inc. | 0.00% | Add +4880.5% | 41,687 | $100K |
| Two Sigma Investments, LP | 0.00% | New | 40,427 | $96K |
| UBS Group AG | 0.00% | Reduce -90.5% | 39,354 | $94K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -12.8% | 38,963 | $93K |
| Susquehanna International Group, LLP | 0.00% | Reduce -41.5% | 35,592 | $85K |
| Northern Trust Corp. | 0.00% | Reduce -2.9% | 33,912 | $81K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -89.2% | 26,890 | $64K |
| Ikarian Capital, LLC | 0.01% | No change | 25,107 | $60K |
| Voleon Capital Management LP | 0.00% | New | 20,950 | $50K |
| Stonepine Capital Management, LLC | 0.04% | New | 20,200 | $48K |
| Group One Trading LLC | 0.00% | New | 17,550 | $42K |
| Squarepoint Ops LLC | 0.00% | Reduce -45.0% | 13,960 | $33K |
| Sequent Planning LLC | 0.01% | Add +19.1% | 12,500 | $30K |
| Mariner, LLC | 0.00% | Reduce -52.2% | 12,193 | $29K |
| FMR LLC | 0.00% | Reduce -36.9% | 11,899 | $28K |
| Sowell Financial Services LLC | 0.00% | Reduce -39.9% | 10,400 | $25K |
| Crewe Advisors LLC | 0.00% | No change | 3,100 | $7K |
| Royal Bank of Canada | 0.00% | Reduce -83.6% | 2,927 | $7K |
| Federated Hermes, Inc. | 0.00% | Add +41.5% | 2,797 | $7K |
| Wells Fargo & Company | 0.00% | Reduce -7.2% | 2,300 | $5K |
| US Bancorp \de | 0.00% | No change | 500 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.7% | 209 | $497 |
| BNP Paribas Financial Markets | 0.00% | Reduce -49.8% | 141 | $336 |
| IFP Advisors, Inc | 0.00% | Add +1.7% | 122 | $290 |
| National Bank of Canada | 0.00% | No change | 80 | $190 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -56.3% | 66 | $157 |
| Jones Financial Companies LLLP | 0.00% | New | 50 | $124 |
| Optiver Holding B.V. | 0.00% | New | 6 | $14 |
| Rossby Financial, LCC | 0.00% | No change | 2 | $5 |
| Barclays PLC | 0.00% | No change | 1 | $2 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -100.0% | 1 | $2 |
"% of holder's portfolio" is JSPR's weight in each manager's 13F, not the share of Jasper Therapeutics Inc. the manager owns.